Management Study Program, Faculty of Economics and Business (FEB), Universitas Sebelas Maret (UNS), organized a Guest Practitioner Lecture for the Business Ethics course entitled “Marketing Ethics and Consumer Protection” on Saturday, 13 December 2025. The activity, conducted virtually via Zoom Meeting, was attended by students of the Management Study Program as part of efforts to enhance practice-based learning, and featured Hersi Rosilani, S.E., M.Si., Vice President of Bio Farma Group, as the invited speaker.

In her presentation, the speaker delivered practical insights into the application of marketing ethics in the pharmaceutical industry, highlighting honesty, transparency of information, regulatory compliance, and corporate responsibility in protecting consumers. Hersi Rosilani explained that the pharmaceutical industry carries a strong social function; therefore, marketing strategies should not be oriented solely toward profit but must also prioritize patient safety and public interest.

The promotion of pharmaceutical products is required to be conducted responsibly, based on scientific evidence, non-misleading, and in accordance with regulations established by the National Agency of Drug and Food Control (BPOM) and the Indonesian Pharmaceutical Code of Ethics. In addition, mechanisms for consumer protection in the pharmaceutical sector were discussed, including consumers’ rights to safety, quality, and accurate information as stipulated in Law Number 8 of 1999 on Consumer Protection.

The speaker also illustrated the supervisory role of BPOM in ensuring drug safety through registration processes, distribution monitoring, and product recalls when violations of quality, safety, or labelling standards are identified.

Through this lecture, students are expected to gain a more comprehensive understanding of ethical business practices, particularly in the context of marketing and consumer protection within strategic industries such as pharmaceuticals. This Practitioner Lecture also served as a platform to enhance contextual learning by presenting real-world practices from industry. The implementation of the activity aligns with efforts to achieve the Sustainable Development Goals (SDGs), particularly SDG 4 (Quality Education) through the enhancement of practice-based learning, SDG 3 (Good Health and Well-Being) through attention to safety and consumer protection in the pharmaceutical sector, and SDG 12 (Responsible Consumption and Production) through the application of responsible business and marketing ethics.